Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|October 24, 2019
Cannabinoid Antagonist Drug Discrimination in Nonhuman PrimatesBrian D Kangas, Ani S Zakarian, Kiran Vemuri, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 19, 2016
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel MonkeysCharles W Schindler, Godfrey H Redhi, Kiran Vemuri, et al.
Current Research in Neurobiology|November 29, 2023
Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adultsMarie-Eve Di Raddo, Marija Milenkovic, Meenalochani Sivasubramanian, et al.
Brain Imaging and Behavior|February 28, 2022
Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 TeslaSarah L Withey, Lei Cao, Fernando B de Moura, et al.
European Journal of Medicinal Chemistry|January 20, 2022
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonistsIoannis P Papanastasiou, Markos-Orestis Georgiadis, Christos Iliopoulos-Tsoutsouvas, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Environmental determinants of ketamine's prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stressAmaya R Jenkins, Daniela B Radl, Thomas J Kornecook, et al.
Drug and Alcohol Dependence|February 28, 2021
Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primatesSarah L Withey, Brian D Kangas, Sophia Charles, et al.
Translational Psychiatry|December 3, 2020
Effects of long-term cocaine self-administration on brain resting-state functional connectivity in nonhuman primatesStephen J Kohut, Dionyssios Mintzopoulos, Brian D Kangas, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2017
Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme InhibitorsMichael Z Leonard, Shakiru O Alapafuja, Lipin Ji, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 10, 2026
Psychedelics produce enduring enhancement of reward responsiveness in male ratsChristopher W Thomas, Kayleigh S LaMalfa, Tobias P Whelan, et al.
Pageof 12